Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Friedmann

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|March 31, 2015
Proton therapy for pediatric and adolescent esthesioneuroblastomaJohn T Lucas, Matthew M Ladra, Shannon M MacDonald, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton studyMatthew M Ladra, Samantha K Edgington, Anita Mahajan, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapyMatthew M Ladra, Henry C Mandeville, Andrzej Niemierko, et al.
Digestive Diseases and Sciences|February 17, 2021
Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case SeriesAlejandro Llanos-Chea, Jason M Shapiro, Rachel W Winter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcomaMatthew M Ladra, Jackie D Szymonifka, Anita Mahajan, et al.
Pediatric Blood & Cancer|May 17, 2013
Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapyAlison M Friedmann, Julie A Wolfson, Melissa M Hudson, et al.
Cancer|June 16, 2018
Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-upSophia C Kamran, Saveli I Goldberg, Karen A Kuhlthau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's diseaseMelissa M Hudson, Matthew Krasin, Michael P Link, et al.
Blood Advances|May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosisBarbara A Degar, Oussama Abla, Patrick K Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|March 31, 2015
Proton therapy for pediatric and adolescent esthesioneuroblastomaJohn T Lucas, Matthew M Ladra, Shannon M MacDonald, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton studyMatthew M Ladra, Samantha K Edgington, Anita Mahajan, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapyMatthew M Ladra, Henry C Mandeville, Andrzej Niemierko, et al.
Digestive Diseases and Sciences|February 17, 2021
Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case SeriesAlejandro Llanos-Chea, Jason M Shapiro, Rachel W Winter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcomaMatthew M Ladra, Jackie D Szymonifka, Anita Mahajan, et al.
Pediatric Blood & Cancer|May 17, 2013
Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapyAlison M Friedmann, Julie A Wolfson, Melissa M Hudson, et al.
Cancer|June 16, 2018
Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-upSophia C Kamran, Saveli I Goldberg, Karen A Kuhlthau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's diseaseMelissa M Hudson, Matthew Krasin, Michael P Link, et al.
Blood Advances|May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosisBarbara A Degar, Oussama Abla, Patrick K Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.
Pageof 5